1.6400
28-February-25 16:45:00
15 minutes delayed
Stocks
-0.0400
-2.38%
Today's range
1.6100 - 1.6800
ISIN
N/A
Source
NASDAQ
MediciNova Receives Notice of Allowance for New Patent Covering the Combination of MN-166 (ibudilast) and Riluzole for the Treatment of Amyotrophic Lateral Sclerosis (ALS) in Japan
18 Jan 2021 18:00:00 By Nasdaq GlobeNewswire
MediciNova Enters into US$20 Million Securities Purchase Agreement with a fund managed by 3D Investment Partners
11 Jan 2021 21:30:00 By Nasdaq GlobeNewswire